Pamboukian Instrumental in Guidelines Development

Salpy PamboukianUntil now, there were no standardized recommendations from the medical community regarding patient selection, surgical preparation, inpatient management and long-term care considerations for mechanical circulatory support patients. That changed this month with the release of new guidelines published in the Journal of Heart and Lung Transplantation.

"There have never been guidelines that were this structured or this comprehensive," said University of Alabama at Birmingham (UAB) cardiologist Salpy Pamboukian, M.D., who co-chaired the committee that drafted the guidelines. She is also medical director of the mechanical circulatory support device program at UAB and co-section head of the section of advanced heart failure, cardiac transplant, mechanical circulatory support and pulmonary vascular disease in UAB Heart and Vascular Services. "There have been a lot of published papers on the management of patients with mechanical assist devices, but never really a best-practices guidelines document; never a comprehensive set of expert-reviewed and agreed-upon recommendations – until now."

Read more at http://www.uab.edu/news/latest/item/3067-uab-expert-co-authors-new-guidelines-for-mechanical-heart-support

Employee of the Month

Becky Wallace has been selected as the Department of Medicine Employee of BeckyWallacethe Month for March 2015!     Becky is an Administrative Associate in the Division of Pulmonary, Allergy and Critical Care Medicine.  She was notified by Jason Daniel, DOM Executive Administrator and Megann Cain, Senior Director of Development and Strategic Planning/DOM Chief of Staff. Read more...

Research Spotlight

Dr. Anthony DiStasiAntonio Di Stasi, MD

Dr. Di Stasi is Assistant Professor of Medicine in the Bone Marrow Transplantation and Cell Therapy Program Unit, where he performs both clinical activity activities and translational research. His primary research focus involves the pre-clinical validation of adoptive T cell immunotherapy strategies for hematologic malignancies, primarily regarding genetic modification of T cells.
Read more...